title: N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.
abstract: Catechol estrogens, especially 4-hydroxylated metabolites of 17beta-estradiol (E(2)), are responsible for estrogen-induced carcinogenesis. 4-Hydroxyestradiol (4-OHE(2)), a major metabolite of E(2) formed preferentially by cytochrome P-450 1B1, is oxidized to E(2)-3,4-quinone, which can react with DNA to yield the depurinating adducts 4-OHE(2)-1-N3Ade and 4-OHE(2)-1-N7Gua. The apurinic sites generated by the loss of these depurinating adducts induce mutations that could lead to cancer initiation. In this study, we have evaluated the effects of N-acetylcysteine (NAcCys) on the metabolism of two cell lines, MCF-10F (a normal human breast epithelial cell line) and E6 (a normal mouse mammary epithelial cell line), treated with 4-OHE(2) or its reactive metabolite, E(2)-3,4-quinone. Extensive HPLC with electrochemical detection and UPLC-MS/MS analyses of the cell media demonstrated that the presence of NAcCys very efficiently shifted the estrogen metabolism toward protective methoxylation and conjugation pathways in multiple ways, whereas formation of depurinating DNA adducts was inhibited. Protection by NAcCys seems to be similar in both cell lines, irrespective of their origin (human or mouse) or the presence of estrogen receptor-alpha. This finding suggests that NAcCys, a common dietary supplement, could be used as a potential chemopreventive agent to block the initial step in the genotoxicity caused by catechol estrogen quinones.
authors.affiliation: Eppley Institute for Research in Cancer and Allied Diseases, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Zahid
authors.forename: Muhammad
authors.initials: M
authors.lastname: Saeed
authors.forename: Mohammed F
authors.initials: MF
authors.lastname: Ali
authors.forename: Eleanor G
authors.initials: EG
authors.lastname: Rogan
authors.forename: Ercole L
authors.initials: EL
authors.lastname: Cavalieri
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000517:prevention & control; D002460:Cell Line; D018736:DNA Adducts / Q000378:metabolism*; D004958:Estradiol / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D002393:Estrogens, Catechol / Q000378:metabolism*; D005260:Female; D006801:Humans; D008321:Mammary Glands, Animal / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000517:prevention & control; D051379:Mice
chemical_list: D000975:Antioxidants; D018736:DNA Adducts; D002393:Estrogens, Catechol; C500988:estradiol-3,4-quinone; D004958:Estradiol; C014036:4-hydroxyestradiol; D000111:Acetylcysteine
references.citation: Cancer Res. 2001 Sep 15;61(18):6716-22
references.pmid: 11559542
references.citation: J Cell Biochem Suppl. 1995;22:33-41
references.pmid: 8538208
references.citation: Carcinogenesis. 2004 Feb;25(2):289-97
references.pmid: 14578156
references.citation: Carcinogenesis. 1998 Jan;19(1):1-27
references.pmid: 9472688
references.citation: FASEB J. 2006 Aug;20(10):1622-34
references.pmid: 16873885
references.citation: Prostate. 2009 Jan 1;69(1):41-8
references.pmid: 18816637
references.citation: Cell Cycle. 2004 Nov;3(11):1451-6
references.pmid: 15492509
references.citation: Ann N Y Acad Sci. 2001 Sep;943:296-315
references.pmid: 11594550
references.citation: J Immunol Methods. 1986 May 22;89(2):271-7
references.pmid: 3486233
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5390-5
references.pmid: 12702779
references.citation: Free Radic Biol Med. 2007 Nov 1;43(9):1289-98
references.pmid: 17893042
references.citation: Cancer Res. 2000 Jan 15;60(2):235-7
references.pmid: 10667565
references.citation: J Steroid Biochem Mol Biol. 2006 Nov;101(4-5):204-15
references.pmid: 16982187
references.citation: Steroids. 2005 Mar;70(3):173-8
references.pmid: 15763595
references.citation: Adv Enzymol Relat Areas Mol Biol. 1969;32:173-219
references.pmid: 4892500
references.citation: J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):150-8
references.pmid: 17582757
references.citation: Int J Cancer. 2008 May 1;122(9):1949-57
references.pmid: 18098283
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42
references.pmid: 9380738
references.citation: Mutat Res. 2001 Oct 1;482(1-2):21-6
references.pmid: 11535245
references.citation: Free Radic Biol Med. 2008 Jul 15;45(2):136-45
references.pmid: 18423413
references.citation: Postgrad Med. 1964 Nov;36:449-53
references.pmid: 14212497
references.citation: J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):357-64
references.pmid: 11162945
references.citation: Free Radic Biol Med. 2009 Jan 15;46(2):253-62
references.pmid: 18996184
references.citation: Oncol Rep. 2005 Oct;14(4):1091-6
references.pmid: 16142378
references.citation: Oncogene. 2001 Nov 29;20(55):7945-53
references.pmid: 11753677
references.citation: Biomed Pharmacother. 2003 May-Jun;57(3-4):145-55
references.pmid: 12818476
references.citation: Eur J Respir Dis Suppl. 1980;111:45-51
references.pmid: 6938410
references.citation: J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
references.pmid: 11959894
references.citation: Free Radic Biol Med. 2007 Dec 1;43(11):1534-40
references.pmid: 17964424
references.citation: Carcinogenesis. 2003 Apr;24(4):697-702
references.pmid: 12727798
references.citation: Oncogene. 2007 May 24;26(24):3587-90
references.pmid: 17160017
references.citation: Free Radic Biol Med. 1990;9(5):381-400
references.pmid: 1705530
references.citation: Chem Res Toxicol. 2007 Dec;20(12):1947-53
references.pmid: 18039013
references.citation: Chem Res Toxicol. 2001 Aug;14(8):1041-50
references.pmid: 11511178
references.citation: Blood Coagul Fibrinolysis. 2006 Jan;17(1):29-34
references.pmid: 16607076
references.citation: J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):22-30
references.pmid: 18226522
references.citation: Chem Res Toxicol. 2006 Jan;19(1):164-72
references.pmid: 16411670
references.citation: Breast Cancer (Auckl). 2009 Jan 06;3:1-8
references.pmid: 21556245
references.citation: Am J Med. 1991 Sep 30;91(3C):122S-130S
references.pmid: 1928203
references.citation: Chem Res Toxicol. 1998 Aug;11(8):909-16
references.pmid: 9705753
references.citation: Chem Res Toxicol. 2006 Mar;19(3):475-9
references.pmid: 16544955
references.citation: Med Toxicol. 1987 Mar-Apr;2(2):93-104
references.pmid: 3574040
references.citation: Cancer Prev Res (Phila). 2008 Jul;1(2):135-45
references.pmid: 19138946
references.citation: J Steroid Biochem. 1986 Jan;24(1):353-6
references.pmid: 3009986
references.citation: Clin Ther. 2000 Feb;22(2):209-21
references.pmid: 10743980
references.citation: Fed Proc. 1987 Apr;46(5):1858-63
references.pmid: 3030825
references.citation: Annu Rev Pharmacol Toxicol. 1990;30:603-31
references.pmid: 2188580
references.citation: Biochim Biophys Acta. 2006 Aug;1766(1):63-78
references.pmid: 16675129
references.citation: Int J Cancer. 2006 Apr 15;118(8):1862-8
references.pmid: 16287077
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):575-9
references.pmid: 10868691